Worcester, University of Massachusetts, MA, USA - 25 Sep `20Study to Evaluate RECELL and MKTP for Repigmentation of Stable Vitiligo Lesions


Official Title: Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

In Brief: Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.

Ages Eligible: 22 Years and older 

Start Date: September 25, 2020

Completion Date (estimated): December 2021

Status: Recruiting

Study ID from ClinicalTrials.gov: NCT04271501
Other Study ID Numbers: CTP008


  • Worcester, University of Massachusetts, MA, USA. Contact: Celia Hartigan at Celia.Hartigan@umassmed.edu    

Contact: To learn more about this study, you or your doctor may contact 

Elizabeth Kirshner
Lisa Carothers

Please refer to this study by its NCT number.

FAQOther Questions

  • How can I cure vitiligo?

    There is no cure for vitiligo, but there are a number of effective treatment options that can be discussed with your GP or dermatologist. The aim of treatment is to stop new pat...

  • PTSD in Vitiligo?

    Vitiligo has long been associated with disease-related discrimination, social stigma, self-isolation, lower self-esteem, embarrassment, anxiety, and depression.  These chronic ...

  • Which skin conditions can be mistaken for vitiligo?

    Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...